Yeh, Hseng-Long; Huang, Li-Ying; Su, Syi; Yang, Ming-Chin; … - In: Health Policy 100 (2011) 2, pp. 196-202
National guidelines recommend angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) therapy for diabetic patients with hypertension and/or proteinuria to hinder renal disease progression. However, little is known about the adequacy of adherence to these...